Tag: T2T

ISAD × LEO Pharma

We are pleased to announce that the International Society of Atopic Dermatitis (ISAD) has been awarded a Research Networking Grant from the LEO Foundation to support the international scientific networking and consolidation workshop for Treat-to-Target in Atopic Dermatitis (T2T-AD) at the Rajka Symposium 2027 in Augsburg, Germany, building on preparatory steps initiated at Rajka Melbourne 2025 and continuing at […]

Read More